Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
Go back to Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer| Fusion Networks Holdings, Inc. (NASDAQ: FUSN) | Delayed: 21.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.55 | 52 Week High | $0.00 | |||
| Open | $21.55 | 52 Week Low | $0.00 | |||
| Day High | $21.55 | P/E | N/A | |||
| Day Low | $21.55 | EPS | $0.00 | |||
| Volume | 372,080 | |||||
